RIVA, BEATRICE
 Distribuzione geografica
Continente #
EU - Europa 748
NA - Nord America 626
AS - Asia 181
AF - Africa 1
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
SA - Sud America 1
Totale 1.559
Nazione #
US - Stati Uniti d'America 615
IT - Italia 237
IE - Irlanda 196
DE - Germania 99
SE - Svezia 88
HK - Hong Kong 48
UA - Ucraina 48
SG - Singapore 39
CN - Cina 33
IN - India 28
FR - Francia 19
GB - Regno Unito 18
BE - Belgio 17
TR - Turchia 13
CA - Canada 11
FI - Finlandia 10
VN - Vietnam 10
IR - Iran 7
CZ - Repubblica Ceca 5
NL - Olanda 4
ES - Italia 2
AE - Emirati Arabi Uniti 1
AT - Austria 1
BG - Bulgaria 1
CH - Svizzera 1
CL - Cile 1
EU - Europa 1
JP - Giappone 1
KR - Corea 1
LT - Lituania 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
RU - Federazione Russa 1
Totale 1.559
Città #
Dublin 193
Jacksonville 92
Chandler 81
Ann Arbor 67
Piemonte 53
Hong Kong 48
Wilmington 28
Singapore 26
Dearborn 25
Bremen 20
Lawrence 20
Princeton 20
Turin 20
Milan 19
Novara 19
Ashburn 18
Munich 18
Beijing 17
Strasbourg 17
San Mateo 16
Brussels 15
Dong Ket 10
Dallas 9
Kocaeli 9
Toronto 7
Andover 6
Torino 6
Asti 5
Boardman 5
Brno 5
Cassano Magnago 5
Vercelli 5
Woodbridge 5
Biella 4
Cagliari 4
Como 4
Helsinki 4
Moncalieri 4
Mülheim 4
Norwalk 4
Seattle 4
Zanjan 4
Bologna 3
Cambridge 3
Castelnuovo Bormida 3
Imola 3
Ipswich 3
Monmouth Junction 3
Sacramento 3
Santa Clara 3
Zola Predosa 3
Alagna Valsesia 2
Augusta 2
Bari 2
Brescia 2
Cureggio 2
Frankfurt am Main 2
Hefei 2
Houston 2
Los Angeles 2
Madrid 2
Nijmegen 2
Noicattaro 2
Ottawa 2
San Francisco 2
Shanghai 2
Waanrode 2
Winnipeg 2
Wustrow 2
Ardabil 1
Auckland 1
Bengaluru 1
Borås 1
Busto Arsizio 1
Cachan 1
Cesano Maderno 1
Chengdu 1
Chiavari 1
Des Moines 1
Fairfield 1
Falkenstein 1
Florence 1
Grafing 1
Grosseto 1
Guangdong 1
Henderson 1
Hummelstown 1
Jiaxing 1
Jinan 1
Kunming 1
Lagos 1
Maccacari 1
Monza 1
Nanchang 1
Nanjing 1
Odalengo Grande 1
Omegna 1
Paris 1
Pusan 1
Rho 1
Totale 1.039
Nome #
Celecoxib targets CML blasts proliferation in a COX-2 independent manner 152
Preparation of 1-​(triazolylphenyl)​-​5-​(trifluoromethyl)​pyrazole compounds useful as SOCE modulators 103
A luminal EF-hand mutation in STIM1 in mice causes the clinical hallmarks of tubular aggregate myopathy. 101
Dissecting the Mechanism of Action of Spiperone— A Candidate for Drug Repurposing for Colorectal Cancer 101
Contribution of hyperpolarizing ion channels to acute cold hypersensitivity induced by oxaliplatin administration 80
Pyrtriazoles, a Novel Class of Store-Operated Calcium Entry Modulators: Discovery, Biological Profiling, and in Vivo Proof-of-Concept Efficacy in Acute Pancreatitis 78
Oxaliplatin-induced cytosolic acidification alters TRP and K2P channel activity in sensory neurons 78
New mechanisms of neurotoxicity related to oxaliplatin chemotherapy in mice 74
Oxaliplatin induces pH acidification in dorsal root ganglia neurons 71
A novel gain-of-function mutation in ORAI1 causes late-onset tubular aggregate myopathy and congenital miosis 69
Celecoxib inhibits proliferation and survival of chronic myelogeous leukemia (CML) cells via AMPK-dependent regulation of β-catenin and mTORC1/2 68
Susceptibility of different mouse strains to oxaliplatin peripheral neurotoxicity: Phenotypic and genotypic insights 64
SiO2nanoparticles modulate the electrical activity of neuroendocrine cells without exerting genomic effects 63
1,2,4-Oxadiazole-Bearing Pyrazoles as Metabolically Stable Modulators of Store-Operated Calcium Entry 63
Early Stimulation of TREK Channel Transcription and Activity Induced by Oxaliplatin-Dependent Cytosolic Acidification 59
Characterization of a functional Ca2+ toolkit in urine-derived stem cells and derived skeletal muscle cells 58
Calcium-related Neurotoxicity of Oxaliplatin: Understanding the Mechanisms to Drive Therapy 56
Store-Operated Calcium Entry as a Therapeutic Target in Acute Pancreatitis: Discovery and Development of Drug-Like SOCE Inhibitors 53
Oxaliplatin-induced neuropathy occurs through impairment of haemoglobin proton buffering and is reversed by carbonic anhydrase inhibitors 51
Unexpected Ca2+-mobilization of oxaliplatin via H1 histamine receptors 47
CIC-39Na reverses the thrombocytopenia that characterizes tubular aggregate myopathy 40
Inhibition of NHE1 transport activity and gene transcription in DRG neurons in oxaliplatin-induced painful peripheral neurotoxicity 39
STIM1 and ORAI1 mutations leading to tubular aggregate myopathies are sensitive to the Store-operated Ca2+-entry modulators CIC-37 and CIC-39 31
Expanding the clinical and genetic spectrum of pathogenic variants in STIM1 14
Totale 1.613
Categoria #
all - tutte 8.707
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.707


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020126 0 0 0 0 0 0 43 4 19 31 28 1
2020/2021228 24 11 20 10 24 16 20 21 22 25 19 16
2021/2022236 19 23 17 20 7 4 10 10 15 34 32 45
2022/2023581 49 24 34 21 61 61 25 30 230 9 28 9
2023/2024176 17 11 17 5 23 4 48 12 1 1 17 20
2024/2025114 19 16 20 11 23 25 0 0 0 0 0 0
Totale 1.613